Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
Key proof-of-principal study that shows that continuous subcutaneous infusion of GLP-1 improves glycaemic control in patients with T2DM
Those numbers matter
Pregnancy and breastfeeding : GLP-1 medications are generally not recommended during pregnancy or breastfeeding
Whilst these mechanisms contribute to improved glycaemic control and weight management, they also produce the characteristic gastrointestinal symptoms
Eli Lilly and Company funded the study, which was designed by Versanis Bio, a wholly owned subsidiary of Eli Lilly and Company
The glucagon suppression is also glucose-dependent
US$ 23.86
US$ 25.73
US$ 21.38
US$ 23.56
US$ 29.94
US$ 21.61
US$ 29.63
